The Utility of Lactate Dehydrogenase as a Prognostic Indicator for Primary Myelofibrosis

Authors

  • Qays Abu-Saymeh, MS-2, Aarya Bestha, MS-1, Shubham Rai, MS-2, Abdulraheem Yacoub, M.D.

DOI:

https://doi.org/10.17161/kjm.vol18.24446

Downloads

Published

2025-09-15

Issue

Vol. 18 No. S3 (2025): Supplement 3: Abstracts from the 2025 KUMC Student Research Forum

Section

Abstracts

License

Copyright (c) 2025 Qays Abu-Saymeh, MS-2, Aarya Bestha, MS-1, Shubham Rai, MS-2, Abdulraheem Yacoub, M.D.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Qays Abu-Saymeh. (2025). The Utility of Lactate Dehydrogenase as a Prognostic Indicator for Primary Myelofibrosis. Kansas Journal of Medicine, 18(S3), 23. https://doi.org/10.17161/kjm.vol18.24446